Standards, Not Predicates Emphasized In Finalized Alternative 510(k) Pathway

Despite pushback from industry, US FDA has moved forward with plans to establish a new alternative 510(k) pathway by finalizing a guidance document that describes the so-called “Safety and Performance Based Pathway” that emphasizes use of consensus standards instead of direct predicate comparisons. 

FDAEntrance_1200x675

A newly finalized guidance document from US FDA emphasizes consensus standards rather than predicate comparisons for establishing substantial equivalence for 510(k) devices.

The new approach, which FDA is calling the "Safety and Performance Based Pathway," effectively expands the abbreviated 510(k) pathway as...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

NextGen Dx Panel Expects Continued Limbo On LDT Regulation

 
• By 

A recent conference panel discussed the stagnation in diagnostics regulation, highlighting the FDA's failed regulatory efforts on lab-developed tests. Political and legislative challenges hinder other reforms, and concerns over Medicare reimbursement cuts loom for the clinical lab industry.

Medtech Must Address AI Risks Now Or Jeopardize Its Future Potential, Expert Warns

 

Urgent action is needed to address gaps in how risks from medical devices and diagnostics utilizing AI are identified, mitigated and managed. So says James Pink, renowned medtech regulatory expert in an interview with Medtech Insight.

No EUDAMED, No Market: ‘Waiting Until Mandatory Deadline Is Risky’

 

EirMed CEO Richard Houlihan warns that EUDAMED (the European database on medical devices) publication delays may harm medical device manufacturers. Currently, only a fraction of the required uploads have occurred, creating potential compliance risks as the mandatory deadline approaches.

Medical Device Recalls Down In Q1 For Lowest Quarterly Count In 3 Years. But Will It Last?

 

Despite a surge in product recalls across five key industries in the first quarter of the year, medical device recalls were down, according to Sedgwick’s latest recall index. But the firm noted they’ve since ticked up.

More from Policy & Regulation